Jefferies Group LLC Axsome Therapeutics, Inc. Call Options Transaction History

Jefferies Group LLC

5 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q2 2022 Aug 15, 2022	SELL	$21.74 - $46.75 $815,249 - $1.75 Million	-37,500 Closed	0 $0
Q1 2022 Sep 21, 2023	BUY	$23.7 - $41.39 $888,750 - $1.55 Million	37,500 New	37,500 $1.55 Million
Q1 2022 May 16, 2022	BUY	$23.7 - $41.39 $888,750 - $1.55 Million	37,500 New	37,500 $1.55 Million
Q2 2019 Aug 14, 2019	SELL	$13.46 - $25.75 $1.61 Million - $3.08 Million	-119,700 Closed	0 $0
Q1 2019 May 15, 2019	BUY	$2.63 - $16.34 $314,811 - $1.96 Million	119,700 New	119,700 $1.7 Million

325

37.7M

912K

855K

Ticker AXSM
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 42,878,000
Market Cap $3.74B
Description
Axsome Therapeutics, Inc., a biopharmaceutical company, engages in the development of novel therapies for central nervous system (CNS) disorders in the United States. The company's product pipeline includes AXS-05, a therapeutic for the treatment of major depressive disorder and resistant depression disorders; and that is in the Phase III clinic...

Get notified when there are updates to the investment portfolio of Jefferies Group LLC, based on Form 13F filings with the SEC.

Stay updated on Jefferies Group LLC with notifications on news.